Monteris Medical (Plymouth, MN), which develops minimally invasive, magnetic resonance imaging (MRI)-guided laser ablation systems for treating brain lesions, has completed a Series C financing round, raising $26.6 million in new equity. The company currently markets the NeuroBlate System in the U.S. and Canada as a surgical tool that provides neurosurgeons an alternative to traditional craniotomies.
Related: Monteris Medical presents new data from trials evaluating laser ablation for brain lesions
The Series C financing was led by Versant Ventures and SightLine Partners, with strong participation from current investors Birchview Capital and BDC Capital's Healthcare Venture Fund. The financing will fund significant investments in R&D, clinical research, and commercial expansion.
For more information, please visit www.monteris.com.